An Analyst Just Declared Eli Lilly the “Clear Winner” of an American Diabetes Association Conference Focused on Weight-Loss Drugs. Novo’s Chief Scientist Disagrees. Who’s Right?
Key Points “The field is getting more crowded — but Lilly is widening its lead,” said RBC analyst…